VIVUS, Inc. Gains 278.87%

Tue 31 Mar 20 at 05:30 PM
VIVUS, Inc. Gains 278.87%

VIVUS, Inc. (VVUS:NASDAQ) rocketted at $3.6, representing a gain of 278.9%. The stock got featured on our News Catalysts scanner on Thu 05 Mar 20 at 06:01 PM in the 'EARNINGS' category. From Mon 16 Mar 20, the stock recorded 60.00% Up Days and 18.18% Green Days

The share price of the company has been moving sideways in recent weeks.


VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.